Liz Simmons is an education staff writer at Forbes Advisor. She has written about higher education and career development for various online publications since 2016. She earned a master’s degree in ...

The Federal Trade Commission has agreed to what it called a “landmark” settlement with Express Scripts, allowing the company to bow out of the agency’s lawsuit against major pharmacy benefit managers ...

Every time Agnes publishes a story, you’ll get an alert straight to your inbox! Enter your email By clicking “Sign up”, you agree to receive emails from ...

Why AI Is Reshaping Computer System Design, And Just About Everything Else At CES, what stood out to me was just how much Nvidia and AMD focused on a systems approach, which may be the most ...

More than a dozen customers at two pharmacies have detailed being given incorrect prescriptions or medicines meant for someone else. Northpharm, which took over the Broome businesses last year, has ...

The Federal Trade Commission reached a settlement with Cigna’s Express Scripts in a case over alleged inflation of insulin prices, according to a Feb. 4 agency news release. With the move, the FTC ...

Network engineers build and maintain the networks that underlie just about everything in the Internet we take for granted. From streaming and 'the cloud' to ordering a lift from a rideshare, our ...

Whether you're a tech junkie or a casual user who's seen every era of computing, you likely have plenty of old tech ephemera in your home. Maybe it's a desk drawer or closet (or even a tote) filled ...

All products featured here are independently selected by our editors and writers. If you buy something through links on our site, Mashable may earn an affiliate commission. Mashable has been testing ...

Daniel Liberto is a journalist with over 10 years of experience working with publications such as the Financial Times, The Independent, and Investors Chronicle. Michael Boyle is an experienced ...

Both Novo Nordisk and Eli Lilly are grappling with pricing pressure in the U.S., but their 2026 outlooks are diverging sharply. While Novo is bracing for a sales decline, Lilly sees revenue charging ...